Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Aliment Pharmacol Ther. 2010 Jan 15;31(2):218-27. doi: 10.1111/j.1365-2036.2009.04183.x. Epub 2009 Oct 26.
The effects of probiotic bacteria in IBS remain controversial.
To study the effects of a probiotic product on IBS symptoms.
We randomized 74 IBS patients to receive 8 weeks of daily treatment with 400 mL milk fermented with the yoghurt bacteria and containing Lactobacillus paracasei, ssp. paracasei F19, Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 (Cultura; active) or acidified milk without these bacteria (control). The primary endpoint was the proportion of subjects reporting adequate relief of their IBS symptoms at least 50% of the weeks. IBS symptom severity, psychological symptoms and quality of life were assessed.
The proportion of responders was 38% (14/37 patients) in the active group and 27% (10/37 patients) in the control group (P = 0.3). IBS symptom severity improved significantly in both groups during the treatment period. This change was greater in the active group during the first 2 weeks, but thereafter, no significant group differences were seen.
We could not detect a clearly positive effect of fermented milk containing three probiotic bacteria on GI symptoms in IBS patients compared with the control treatment. However, a trend towards a more favourable effect during the first weeks was seen in the active group.
益生菌对 IBS 的影响仍存在争议。
研究益生菌产品对 IBS 症状的影响。
我们将 74 名 IBS 患者随机分为两组,分别接受 8 周的每日治疗,一组服用含有嗜酸乳杆菌 La5 和双歧杆菌 Bb12 的酸奶发酵牛奶(400 毫升,Cultura;活性组),另一组服用不含这些细菌的酸化牛奶(对照组)。主要终点是报告 IBS 症状至少缓解 50%周数的患者比例。评估 IBS 症状严重程度、心理症状和生活质量。
活性组的应答者比例为 38%(37 例患者中的 14 例),对照组为 27%(37 例患者中的 10 例)(P = 0.3)。在治疗期间,两组的 IBS 症状严重程度均显著改善。在治疗的前 2 周,活性组的改善更为明显,但此后,两组间未见显著差异。
与对照组相比,我们未能发现含有三种益生菌的发酵牛奶对 IBS 患者的胃肠道症状有明显的积极影响。然而,在活性组中,我们观察到在前几周有更有利的趋势。